Abaxis Return on Equity:
16.24% for Dec. 31, 2012Abaxis Historical Return on Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 16.24% |
| Dec. 31, 2012 | 15.48% |
| Sept. 30, 2012 | 14.49% |
| June 30, 2012 | 8.62% |
| March 31, 2012 | 8.17% |
| Dec. 31, 2011 | 7.31% |
| Sept. 30, 2011 | 7.90% |
| June 30, 2011 | 8.14% |
| March 31, 2011 | 9.25% |
| Dec. 31, 2010 | 9.10% |
| Sept. 30, 2010 | 9.16% |
| June 30, 2010 | 9.08% |
| March 31, 2010 | 9.53% |
| Dec. 31, 2009 | 9.85% |
| Sept. 30, 2009 | 10.20% |
| June 30, 2009 | 10.73% |
| March 31, 2009 | 10.37% |
| Dec. 31, 2008 | 11.53% |
| Sept. 30, 2008 | 11.96% |
| June 30, 2008 | 12.10% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Return on Equity (ROE)
Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).
ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.
Investors generally are interested in company's that have high, increasing returns on equity.
Learn More
ABAX Return on Equity Benchmarks
| Companies | |
|---|---|
| Meridian Bioscience | 25.23% |
| Alere | -4.84% |
| Trinity Biotech | 10.77% |
ABAX Return on Equity Rankings
| Overall |
86th percentile 996 of 7593 |
| Sector |
85th percentile 92 of 650 in Healthcare |
| Industry |
80th percentile 12 of 61 in Diagnostics & Research |
ABAX Return on Equity Range, Past 5 Years
| Minimum | 7.31% | Dec 2011 |
| Maximum | 16.24% | Mar 2013 |
| Average | 10.46% |
